1-13 of 13
Sho Ikeda
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Multiple Myeloma with 1q Gain/Amplification Shows Reduced CD38 Expression Via IL-6R Overexpression

Wataru Kuroki, Akihiro Kitadate, Masahiro Yamada, Sayaka Iwama, Yuto Takahashi, Yuki Fujioka, Takahiro Kobayashi, Sho Ikeda, Kentaro Narita, Kosei Matsue, Naoto Takahashi
Journal: Blood
Blood (2023) 142 (Supplement 1): 637.
https://doi.org/10.1182/blood-2023-173494
Published: 2023
Journal Articles

Tumor Suppressive Mir-7 Targeting PSME3 Improves the Efficacy of Histone Deacetylases Inhibitors in Multiple Myeloma

Masahiro Yamada, Sho Ikeda, Wataru Kuroki, Sayaka Iwama, Yuto Takahashi, Akihiro Kitadate, Fumito Abe, Hiroyuki Tagawa, Naoto Takahashi
Journal: Blood
Blood (2023) 142 (Supplement 1): 6592.
https://doi.org/10.1182/blood-2023-173475
Published: 2023
Journal Articles

STAT3 Is a Potential Therapeutic Target for Histone Deacetylase Inhibitor-Resistant Cutaneous T-Cell Lymphoma

Yuto Takahashi, Akihiro Kitadate, Sho Ikeda, Sayaka Iwama, Ko Abe, Hiroyuki Tagawa, Hideki Wakui, Naoto Takahashi
Journal: Blood
Blood (2022) 140 (Supplement 1): 5971–5972.
https://doi.org/10.1182/blood-2022-165113
Published: 2022
Journal Articles

Hypoxia-Induced Oxidative Stress Promotes Proteasome Inhibitor Resistance Via Upregulation of Heme Oxygenase-1 in Multiple Myeloma

Ko Abe, Sho Ikeda, Miho Nara, Akihiro Kitadate, Hiroyuki Tagawa, Naoto Takahashi
Journal: Blood
Blood (2022) 140 (Supplement 1): 9974–9975.
https://doi.org/10.1182/blood-2022-159825
Published: 2022
Journal Articles

Hexokinase-2 Regulates Hypoxia-Inducible Autophagy, Leading to Enhance Anti-Apoptotic Capability of Refractory Multiple Myeloma

Sho Ikeda, MD PhD, Fumito Abe, MD PhD, Matsuda Yuka, Akihiro Kitadate, MD PhD, Takahiro Kobayashi, MD PhD, Naoto Takahashi, MD PhD, Hiroyuki Tagawa, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1787.
https://doi.org/10.1182/blood-2019-123360
Published: 2019
Journal Articles

Correlation between Changes in Granzyme B Expression and Time to Progression in Patients with Newly Diagnosed Multiple Myeloma Treated with Lenalidomide and Dexamethasone Therapy

Takahiro Kobayashi, MD PhD, Yuki Fujioka, MD PhD, Sho Ikeda, MD PhD, Hiroyoshi Nishikawa, MD PhD, Naoto Takahashi, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1792.
https://doi.org/10.1182/blood-2019-125649
Published: 2019
Journal Articles

Histone Deacetylase Inhibitors Downregulate CCR4 Expression and Decrease Mogamulizumab Efficacy in CCR4-Positive Mature T-Cell Lymphomas

Akihiro Kitadate, MD, Sho Ikeda, MD, Fumito Abe, MD PhD, Naoto Takahashi, MD PhD, Norio Shimizu, PhD, Kosei Matsue, MD PhD, Hiroyuki Tagawa, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 720.
https://doi.org/10.1182/blood.V130.Suppl_1.720.720
Published: 2017
Journal Articles

Hypoxia-Inducible KDM3A Addiction in Multiple Myeloma

Sho Ikeda, MD, Akihiro Kitadate, MD, Fumito Abe, MD PhD, Naoto Takahashi, Hiroyuki Tagawa, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3061.
https://doi.org/10.1182/blood.V130.Suppl_1.3061.3061
Published: 2017
Journal Articles

Histone Deacetylase Inhibitors Inhibit Metastasis By Restoring a Tumor Suppressive microRNA, Mir-150 in Advanced Cutaneous T-Cell Lymphoma

Akihiro Kitadate, MD PhD, Fumito Abe, MD, Sho Ikeda, MD PhD, Junsuke Yamashita, Naoto Takahashi, MD PhD, Makoto Sugaya, MD PhD, Hiroyuki Tagawa, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4113.
https://doi.org/10.1182/blood.V128.22.4113.4113
Published: 2016
Journal Articles

Hypoxia Inducible microRNA-210 Regulates the DIMT1-IRF4 Oncogenetic Axis in Multiple Myeloma

Sho Ikeda, MD PhD, Akihiro Kitadate, MD PhD, Fumito Abe, MD, Naoto Takahashi, MD PhD, Hiroyuki Tagawa, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2058.
https://doi.org/10.1182/blood.V128.22.2058.2058
Published: 2016
Journal Articles

Microrna-16 Mediates the Regulation of a Senescence-Apoptosis Switch in Cutaneous T-Cell and Other Non-Hodgkin Lymphomas

Akihiro Kitadate, MD, Sho Ikeda, MD, Kazuaki Teshima, MD PhD, Mitsugu Ito, MD PhD, Naoto Takahashi, MD PhD, Tomomitsu Miyagaki, MD PhD, Makoto Sugaya, MD PhD, Hiroyuki Tagawa, MD PhD
Journal: Blood
Blood (2015) 126 (23): 467.
https://doi.org/10.1182/blood.V126.23.467.467
Published: 2015
Journal Articles

MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6, in advanced cutaneous T-cell lymphoma

Mitsugu Ito, Kazuaki Teshima, Sho Ikeda, Akihiro Kitadate, Atsushi Watanabe, Miho Nara, Junsuke Yamashita, Koichi Ohshima, Kenichi Sawada, Hiroyuki Tagawa
Journal: Blood
Blood (2014) 123 (10): 1499–1511.
https://doi.org/10.1182/blood-2013-09-527739
Published: 2014
Includes: Supplemental data
Journal Articles

Microrna-150 Inhibits Tumor Invasion and Metastasis By Targeting The Chemokine Receptor CCR6 In Advanced Cutaneous T-Cell Lymphoma

Mitsugu Ito, MD, Kazuaki Teshima, MD, Sho Ikeda, MD, Atsushi Watanabe, MD, PhD, Miho Nara, MD, Akihiro Kitadate, MD, Junsuke Yamashita, Koichi Oshima, MD, PhD, Kenichi Sawada, MD, PhD, Hiroyuki Tagawa, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4248.
https://doi.org/10.1182/blood.V122.21.4248.4248
Published: 2013